Currency in SEK
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 0.95 | 0.97 | 4.11 | 4.53 |
Low estimate | 0.9 | 0.9 | 4 | 4.37 |
High estimate | 1 | 1.04 | 4.22 | 4.69 |
Year ago EPS | 0.8 | 1.01 | 3.62 | 4.11 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 358M | 342.5M | 1.43B | 1.6B |
Low estimate | 353M | 336M | 1.43B | 1.59B |
High estimate | 363M | 349M | 1.43B | 1.61B |
Year ago sales | 315.22M | 317.69M | 1.3B | 1.43B |
Sales growth (year/est) | 13.60% | 7.80% | 10.30% | 11.80% |
Earnings history | 30/06/2023 | 30/09/2023 | 31/12/2023 | 31/03/2024 |
---|
Est. EPS | 0.74 | 0.78 | 0.59 | 0.96 |
Actual EPS | 0.8 | 1.01 | 0.67 | 1.21 |
Difference | 0.06 | 0.23 | 0.08 | 0.25 |
Surprise % | 8.10% | 29.50% | 13.60% | 26.00% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 0.95 | 0.97 | 4.11 | 4.53 |
7 days ago | 0.95 | 0.97 | 4.11 | 4.53 |
30 days ago | 0.98 | 1.06 | 4.13 | 4.5 |
60 days ago | 1.02 | 1.01 | 3.96 | 4.39 |
90 days ago | 1.02 | 0.96 | 3.96 | 4.39 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | 1 | 1 | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIOG-B.ST | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 18.70% | N/A | N/A | N/A |
Next qtr. | -4.00% | N/A | N/A | N/A |
Current year | 13.50% | N/A | N/A | N/A |
Next year | 10.20% | N/A | N/A | N/A |
Next 5 years (per annum) | 16.50% | N/A | N/A | N/A |
Past 5 years (per annum) | 18.87% | N/A | N/A | N/A |